Pharmaceutical Manufacturing and Formulation

The contract entails the manufacturing of FDA-compliant Clobetasol Propionate Lotion and Cream at a 0.05% concentration, packaged in 15 gm tubes, covering full production from active pharmaceutical ingredient sourcing through compounding and rigorous quality control procedures. The work must adhere strictly to regulatory standards ensuring safety, efficacy, and consistency, with all processes meeting current Good Manufacturing Practices as required by the FDA. The manufacturing facility is expected to maintain full traceability of materials, validate all processes, and provide comprehensive documentation to support regulatory compliance. The performance location is designated as Fort Stewart, Georgia, with a zip code of 31314-5185, and the solicitation falls under NAICS code 325412 for pharmaceutical preparation manufacturing. This is a subcontract opportunity issued by the Department of Defense via the Medical Supply Chain Pharm FSA, with a response deadline of July 22, 2026. The contract requires the vendor to demonstrate proven experience in sterile and topical pharmaceutical production, robust quality assurance systems, and the capacity to meet volume and delivery timelines without compromise to product integrity or compliance.